Virtu Financial LLC Dbv Technologies S.A. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024
BUY
$0.7 - $1.33 $8,788 - $16,698
12,555 New
12,555 $12,000
Q1 2022

May 17, 2022
SELL
$1.22 - $1.77 $64,955 - $94,238
-53,242 Closed
0 $0
Q4 2021

Feb 17, 2022
BUY
$1.39 - $5.58 $74,006 - $297,090
53,242 New
53,242 $85,000
Q3 2020

Dec 11, 2020
SELL
$1.58 - $4.77 $42,394 - $127,988
-26,832 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$3.74 - $6.28 $100,351 - $168,504
26,832 New
26,832 $118,000

Others Institutions Holding DBVT

# of Institutions
4
Shares Held
253K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $137M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email